NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd. (NRSN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NRSN · as of Jun 9, 2026
Key Statistics
Explore NeuroSense Therapeutics Ltd. Data
nrsn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 50.0%
Competitors & Peers
nrsn competitorsNRSN
CLGN
CVKD
ENLV
KLTO
NERVStock Performance
Full HistoryAbout NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neuro…
what is neurosense therapeutics ltd. · nrsn stock overview · neurosense therapeutics ltd. company profile · who is neurosense therapeutics ltd. ceo · nrsn NASDAQ · neurosense therapeutics ltd. headquarters · neurosense therapeutics ltd. business segments
About Stock Overview & Key Data
NeuroSense Therapeutics Ltd. (NRSN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 9, 2021. As of the latest trading session, NRSN stock price is $0.75, with a market capitalization of $18.5M. The stock has returned -60.44% over the past 12 months and -2.26% year-to-date.
According to 2 Wall Street analysts, the consensus rating for NeuroSense Therapeutics Ltd. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, NeuroSense Therapeutics Ltd. reported revenue of — and net income of -$11.1M. For detailed data — including NeuroSense Therapeutics Ltd. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NeuroSense Therapeutics Ltd. (NRSN) stock price is $0.75. The stock is traded on NASDAQ under the ticker symbol NRSN. The 52-week range is $0.63 – $2.60.